Blueprint Medicines, a Sanofi company, is a global, fully integrated biopharmaceutical organization dedicated to inventing life-changing medicines. With a focus on alleviating human suffering, the company addresses significant medical challenges in allergy/inflammation and oncology/hematology. Blueprint Medicines employs deep scientific knowledge and drug discovery expertise to target the root causes of diseases, resulting in a proven track record of success with approved therapies, including treatments for systemic mastocytosis. The company is committed to advancing a diverse pipeline of innovative therapies, leveraging its established research, development, and commercial capabilities to scale its impact in treating mast cell disorders and various cancers. Blueprint Medicines fosters a culture of collaboration and innovation, empowering its team to break through norms and drive success in the biopharmaceutical landscape.